Compare aixbt (AIXBT) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
aixbt vs Mira — how do they compare? aixbt trades at Rp312.07 (market cap Rp314,18M, Rp71,81M 24h volume), while Mira trades at Rp700.02 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: aixbt is the larger of the two by market cap, and aixbt's circulating supply is 998,9M / 1B AIXBT (100%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold aixbt for 23 Days and Mira for 22 Days on average.
| AIXBT | MIRA | |
|---|---|---|
Market Cap | Rp314,18M | Rp226,43M |
Volume (24h) | Rp71,81M | Rp101,47M |
Circulating Supply | 998,9M / 1B AIXBT (100%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 23 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AIXBT trades at Rp324.15 with a market cap of Rp324.28M, showing neutral technical signals overall. The asset is fully circulated with a 100% supply distribution and average hold time of 23 days. Current price sits near the pivot point of Rp330, with immediate resistance at Rp344 and support at Rp309. Moving averages indicate bearish momentum while oscillators remain neutral, suggesting consolidation phase.
Outlook remains cautious with neutral bias. Key opportunity lies in potential breakout above Rp344 resistance, while major risks include limited liquidity and high volatility. The fully distributed supply reduces inflation concerns but may limit upside momentum without new ecosystem developments.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About aixbt
AIXBT is an AI-powered crypto platform that gives token holders an edge in the fast-moving market. It uses advanced analysis to track trends and provide actionable insights. The platform integrates various data sources for better decision-making.
Read more on AIXBT →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
